Rein Therapeutics Inc (RNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,336 | 10,660 | 11,951 | 20,740 | 0 |
| Marketable Securities | 12,967 | 10,060 | 38,889 | 0 | 0 |
| TOTAL | $19,550 | $21,775 | $51,840 | $21,073 | $0 |
| Non-Current Assets | |||||
| PPE Net | 295 | 7,290 | 154 | 107 | 0 |
| Other Non-Current Assets | 6,628 | 1,247 | 694 | 841 | 0 |
| TOTAL | $6,923 | $8,537 | $848 | $948 | $N/A |
| Total Assets | $26,473 | $30,312 | $52,688 | $22,021 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,452 | 1,731 | 1,600 | 1,971 | 0 |
| Accrued Expenses | 3,941 | 3,639 | 3,291 | 2,100 | 0 |
| TOTAL | $5,839 | $5,370 | $4,891 | $4,071 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 5,342 | N/A | N/A | 0 |
| Other Non-Current Liabilities | 4,586 | 0 | 0 | 129,745 | 0 |
| TOTAL | $4,586 | $5,342 | $N/A | $129,756 | $N/A |
| Total Liabilities | $10,425 | $10,712 | $4,891 | $133,827 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,391 | 744 | 737 | N/A | N/A |
| Common Shares | 28 | 15 | 15 | 0 | 0 |
| Retained earnings | -198,135 | -168,493 | -136,946 | -114,342 | 0 |
| Other shareholders' equity | 7 | -5 | -33 | 0 | 0 |
| TOTAL | $16,048 | $19,600 | $47,797 | $-111,806 | $0 |
| Total Liabilities And Equity | $26,473 | $30,312 | $52,688 | $22,021 | $0 |